Caption Management, LLC Galapagos Nv Transaction History

Caption Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$36.5 - $48.0 $188,851 - $248,352	-5,174 Reduced 20.7%	19,826 $766,000
Q4 2022 Feb 14, 2023	BUY	$37.44 - $46.51 $936,000 - $1.16 Million	25,000 New	25,000 $1.11 Million
Q2 2022 Aug 15, 2022	SELL	$52.3 - $71.59 $109,830 - $150,339	-2,100 Reduced 35.0%	3,900 $218,000
Q1 2022 May 13, 2022	SELL	$51.32 - $68.5 $1.23 Million - $1.64 Million	-24,000 Reduced 80.0%	6,000 $373,000
Q4 2021 Feb 11, 2022	SELL	$47.03 - $57.12 $1.26 Million - $1.53 Million	-26,800 Reduced 47.18%	30,000 $1.65 Million
Q2 2021 Aug 16, 2021	SELL	$68.86 - $83.34 $1.02 Million - $1.23 Million	-14,767 Reduced 20.63%	56,800 $3.91 Million
Q1 2021 May 17, 2021	BUY	$76.15 - $111.94 $3.28 Million - $4.82 Million	43,067 Added 151.11%	71,567 $5.52 Million
Q4 2020 Feb 16, 2021	BUY	$96.85 - $148.25 $2.76 Million - $4.23 Million	28,500 New	28,500 $2.82 Million

12.3M

69.1K

42.7K

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.87B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.